Quality of life considerations in the treatment of metastatic hormone-sensitive prostate cancer

Authors

Suzanne K. Chambers, Edith Cowan UniversityFollow
Mark Frydenberg
Jeff Dunn

Document Type

Other

Publication Title

The Lancet Oncology

Volume

20

Issue

11

First Page

1469

Last Page

1471

PubMed ID

31578172

Publisher

Elsevier

School

Exercise Medicine Research Institute

Comments

Chambers, S. K., Frydenberg, M., & Dunn, J. (2019). Quality of life considerations in the treatment of metastatic hormone-sensitive prostate cancer. The Lancet Oncology, 20(11), 1469-1471.

Available here.

DOI

10.1016/S1470-2045(19)30628-X

Access Rights

subscription content